Apogee Therapeutics
(NASDAQ) APGE
Apogee Therapeutics Financials at a Glance
Market Cap
$5.85B
Revenue (TTM)
$0.00
Net Income (TTM)
$255.84M
EPS (TTM)
$-4.21
P/E Ratio
-19.97
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$84.25
Volume
23,531
Open
$85.34
Price
$84.25
Volume
23,531
Open
$85.34
Previous Close
$84.25
Daily Range
$83.81 - $85.89
52-Week Range
$26.20 - $85.89
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$84.25
Volume
23,531
Open
$85.34
Previous Close
$84.25
Daily Range
$83.81 - $85.89
52-Week Range
$26.20 - $85.89
APGE News
APGE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Apogee Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
261
CEO
Michael Henderson, MD
Website
www.apogeetherapeutics.comHeadquarters
Waltham, MA 02453, US
APGE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-32%
Return on Capital
-31%
Return on Assets
-27%
Earnings Yield
-5.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.85B
Shares Outstanding
69.49M
Volume
23.53K
Short Interest
0.00%
Avg. Volume
1.10M
Financials (TTM)
Gross Profit
$1.42M
Operating Income
$285.60M
EBITDA
$284.18M
Operating Cash Flow
$227.45M
Capital Expenditure
$5.15M
Free Cash Flow
$232.60M
Cash & ST Invst.
$730.19M
Total Debt
$8.85M
Apogee Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$400.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.85B
N/A
Market Cap/Employee
$29.84M
N/A
Employees
196
N/A
Net Income
$69.39M
-3.2%
EBITDA
$77.65M
-2.4%
Quarterly Fundamentals
Net Cash
$721.34M
+41.8%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$5.34M
-37.8%
Short Term Debt
$3.50M
+8.3%
Return on Assets
-27.30%
N/A
Return on Invested Capital
-31.41%
N/A
Free Cash Flow
$62.75M
+7.3%
Operating Cash Flow
$62.69M
+7.4%